Marinus Pharmaceuticals, Inc.Marinus Pharmaceuticals, Inc.Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

No trades
See on Supercharts

MRNS fundamentals

An in-depth look to Marinus Pharmaceuticals, Inc. operating, investing, and financing activities

MRNS free cash flow for Q2 24 is -30.88 M USD. For 2023, MRNS free cash flow was -118.12 M USD and operating cash flow was -118 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth